INVO Fertility Aktie News

SARASOTA, Fla., 20. Aug. 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" oder das "Unternehmen"), ein Gesundheitsunternehmen im Bereich Fruchtbarkeit, das sich auf Aufbau, Übernahme und Betrieb von Fruchtbarkeitskliniken sowie verwandten Geschäften und Technologien konzentriert, gab heute bekannt, dass Gretchen Collins, M.D.

Der Umsatz im Q2 2026 stieg um 17 %, während INVO organisches Wachstum vorantreibt und eine disziplinierte Akquisitionsstrategie verfolgt, die sich auf etablierte, profitable Fertilitätspraxen konzentriert Die Klinikplattform war auf bereinigter EBITDA-Basis vor Unternehmensbetriebskosten und Kosten einer börsennotierten Gesellschaft profitabel SARASOTA, Fla., 17. Aug. 2026 (GLOBE NEWSWIRE) -- ...

23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet

SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company, today announced that on May 27, 2026, it received a delinquency notice (the "Notice") from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)...

SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced fiscal year 2025 financial results.

SARASOTA, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that on April 23, 2026, it received a written noti...

SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-5 reverse split of its issued and outstanding and of its authorized common stock effective as of 12:01 a.m. Eastern Time on March 27, 2026. Commencing with the opening of trading on The Nasdaq Capital Ma...